We are live on ! Find out more
NVCR icon

NovoCure
NVCR

128 hedge funds and large institutions have $778M invested in NovoCure in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

352% more call options, than puts

Call options by funds: $20.2M | Put options by funds: $4.46M

240% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 10

54% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 28

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

23% more funds holding

Funds holding: 104 → 128 (+24)

4% more capital invested

Capital invested by funds: $746M → $778M (+$31.9M)

0.87% more ownership

Funds ownership: 42.2% → 43.07% (+0.87%)

Holders
128
Holders Change
+24
Holders Change %
+23.08%
% of All Funds
2.9%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
34
Increased
43
Reduced
28
Closed
10
Calls
$20.2M
Puts
$4.46M
Net Calls
+$15.7M
Net Calls Change
-$3.94M

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$22.4M
2
WRF
Waddell & Reed Financial
Kansas
+$17M
3
GPP
Great Point Partners
Connecticut
+$13.5M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$11.6M
5
Allianz Asset Management
Allianz Asset Management
Germany
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$92.1M
2
PC
PointState Capital
New York
-$14.9M
3
AC
Ascend Capital
California
-$13M
4
LCM
Laurion Capital Management
New York
-$9.29M
5
JG
Jefferies Group
New York
-$6.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
GHCM
101
Glen Harbor Capital Management
California
$164K – – –
Bank of Montreal
102
Bank of Montreal
Ontario, Canada
$143K – – –
Simplex Trading
103
Simplex Trading
Illinois
$123K +$68K +3,533 +136%
SG Americas Securities
104
SG Americas Securities
New York
$120K -$262K -13,590 -70%
CPP
105
Crow Point Partners
Massachusetts
$120K +$113K +5,855 New
PNC Financial Services Group
106
PNC Financial Services Group
Pennsylvania
$108K +$104K +5,380 New
AIP
107
Ameritas Investment Partners
Nebraska
$102K – – –
KBC Group
108
KBC Group
Belgium
$95K +$91K +4,724 New
TRCT
109
Tower Research Capital (TRC)
New York
$57K -$138K -7,155 -72%
Zurich Cantonal Bank
110
Zurich Cantonal Bank
Switzerland
$57K +$39.6K +2,055 +276%
EWM
111
Evercore Wealth Management
New York
$54K +$52K +2,700 New
AAMU
112
Amundi Asset Management US
Massachusetts
$42K +$39.8K +2,066 New
UBS Group
113
UBS Group
Switzerland
$41K -$117K -6,071 -75%
FDCDDQ
114
Federation des caisses Desjardins du Quebec
Quebec, Canada
$40.2K – – –
CG
115
Cutler Group
California
$26K -$61.1K -3,171 -71%
BCM
116
Blume Capital Management
California
$20K – – –
AIM
117
Advantage Investment Management
Iowa
$10K – – –
AWM
118
Aevitas Wealth Management
Massachusetts
$10K +$9.63K +500 New
AG
119
Advisor Group
Arizona
$8K – – –
WAS
120
Winch Advisory Services
Wisconsin
$6K -$5.78K -300 -50%
TDC
121
Thompson Davis & Co
Virginia
$5K +$4.81K +250 New
Federated Hermes
122
Federated Hermes
Pennsylvania
$2K -$173 -9 -9%
RBC
123
Roble Belko & Company
Pennsylvania
$2K – – –
VDFA
124
Vickerman & Driscoll Financial Advisors
Washington
$2K +$1.93K +100 New
LTFS
125
Ladenburg Thalmann Financial Services
Florida
$1K -$38.5K -2,000 -98%
2 3 4
5
6

NVCR Hedge Fund Activity: Q4 2017 in Review

128 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2017, worth a combined $778M — up 4.3% from $746M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NVCR positions and 10 closed out — a net gain of 24 holders — while 43 added to existing stakes and 28 trimmed.

The largest buyer was Farallon Capital Management, opening a new position worth an estimated $22.4M. The largest seller was Goldman Sachs, cutting an estimated $92.1M.

  • 128 institutional investors held NovoCure (NVCR) as of Q4 2017, up from 104 in Q3 2017.
  • Funds reported $778M of NovoCure stock for Q4 2017, up 4.3% quarter-over-quarter.
  • 34 funds opened new NovoCure positions in Q4 2017 and 10 closed out, a net change of +24 holders.
  • The largest NovoCure buyer in Q4 2017 was Farallon Capital Management, an estimated $22.4M added.
  • The largest NovoCure seller in Q4 2017 was Goldman Sachs, an estimated $92.1M sold.

Based on aggregated 13F filings for Q4 2017.